Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled ...

Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsSean Christensen - Vice President of Finance and ...

Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report the ...

Instead of making life easier for medical device companies, the FDA’s new wearables guidance makes the market more complex.

Fortem Technologies, the global leader in airspace security and counter-drone solutions, today announced it has completed what it believes is the first autonomous 5-vs-5 drone intercept with safe ...

Shore Group, a traditional outsource staffing provider since 2006, today announced it has completed a three-year transformation into an AI-enabled operations company and launched Shore Digital ...

Dexcom announced a new wave of AI-powered features designed to help users understand how food and daily habits affect their metabolic health.

Jacob Steven Leach, DexCom, Inc.'s President and CEO who will summarize our recent highlights and ongoing strategic initiatives. Please note that there are also slides available related to our fourth ...

New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

Dexcom DXCM recently announced an upcoming nationwide rollout of an AI-driven upgrade to its Stelo platform aimed at improving users’ understanding of glucose health and supporting long-term wellness ...

As patients and employers look for alternatives to pricey GLP-1 drugs, Silicon Valley startup Twin Health is using AI and wearable sensors to help people make healthier choices. Rodney Buckley has ...